Journal of Bioequivalence & Bioavailability

Effects of drying technology and polymers on integrity and biological activity of proteins

International Conference and Exhibition on Biowaivers & Biosimilars

September 10-12, 2012 Hilton San Antonio Airport, USA

Amal Ali Elkordy

Scientific Tracks Abstracts: J Bioequiv Availab

Abstract:

David Goodall is CSO and founder of Paraytec Limited, based in York, UK. Paraytec?s main customer focus is to provide early insights for those working in analytical and preformulations R&D and assessing developability of biopharmaceuticals and pharmaceuticals. David is also Emeritus Professor of Chemistry at the University of York, where his speciality was analytical science and instrumentation. He is the author of over 150 papers and has received awards from the Chromatographic Society and the Royal Society of Chemistry. Collaborative work with industrial and academic partners includesa project characterising protein aggregation during which prototypes of the instruments were developed

Biography :

Amal Ali Elkordy is a Senior Lecturer in Pharmaceutics in the Department of Pharmacy, Health and Well-being. Her area of research interest is the stabilisation of protein formulations (using spray drying and crystallisation technology) and their delivery via oral and pulmonary routes. Her work in this field has been recognised by the award of two prizes at the British Pharmaceutical Conference in 2002 and in 2004. Her more recent work is concerned with the enhancement of poorly water soluble drugs, resulting in the award of two prizes at the British Pharmaceutical Conference 2008 and at the British Pharmaceutical Students? Association Annual Conference 2010. She also has research interests in: ? Gene therapeutics (awarded national recognition from the College of Mental Health Pharmacists, 2010) ? Liposomal drug delivery and preparation of drug eluting stents for the treatment of restenosis.